About: Sansum Clinic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sansum Clinic Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
owl:sameAs	Sansum Clinic
description	americká firma (cs)
rdfs:label	Sansum Clinic (de) Sansum Clinic (en) Sansum Clinic (es) Sansum Clinic (fr) Sansum Clinic (it) Sansum Clinic (nl)
skos:prefLabel	Sansum Clinic (de) Sansum Clinic (en) Sansum Clinic (es) Sansum Clinic (fr) Sansum Clinic (it) Sansum Clinic (nl)
name	Sansum Clinic (de) Sansum Clinic (en) Sansum Clinic (es) Sansum Clinic (fr) Sansum Clinic (it) Sansum Clinic (nl)
Freebase ID	wds:Q17066381-A8E8C340-536F-4100-99E4-5AD277F44C79
Freebase ID	/m/0_1gzr0
ROR ID	wds:Q17066381-77C19619-BC26-4B2E-9F27-E1A12BECB837
ROR ID	04rx0dh54
instance of	wds:Q17066381-B44D1212-DB2B-4A16-92AC-5E79D6392EBB
instance of	business
country	wds:Q17066381-DD45D243-DBF7-41E7-9351-C69A36ED3655
country	United States of America
Ringgold ID	wds:Q17066381-4BCD4FE4-C362-4C18-8A49-FCDC32842A7D
Ringgold ID	426418
inception	wds:Q17066381-7FE6A562-4AFB-4220-A273-EF979E4C0194
inception	1921-01-01 00:00:00Z (xsd:dateTime)
headquarters location	wds:Q17066381-3865FBC5-E3F4-4AAD-A55B-6A86EE888B23
headquarters location	Santa Barbara
Crunchbase organization ID	wds:Q17066381-026E846C-BF80-4F04-86B8-78791DC4FA78
ISNI	wds:Q17066381-DC81F4E6-FEFA-46E8-B2AD-CA4F2D2BA147
Microsoft Academic ID	wds:Q17066381-FA4E70F5-6B69-47A1-975F-785E0E1D9804
location of formation	wds:Q17066381-C32B4C5C-65D1-4180-95EC-24D67C91C5EF
official website	wds:Q17066381-A92F60A3-8E33-4F4D-AE21-2BE557E48AEA
Microsoft Academic ID	https://makg.org/entity/2801628713
Crunchbase organization ID	sansum-clinic
ISNI	0000000449034172
Microsoft Academic ID	2801628713
location of formation	Santa Barbara
official website	http://www.sansumclinic.org/
GRID ID	wds:Q17066381-EAF2C81D-BD94-47AA-B70B-6AC422CE9634
industry	wds:Q17066381-5803964D-8B17-4FF9-ABB2-624452D5AEF4
GRID ID	grid.415145.0
industry	health care
is about of	Sansum Clinic https://www.wikidata.org/wiki/Special:EntityData/Q17066381 Sansum Clinic
is research site of	A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). Palbociclib in Real World Practice Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS) BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer [DESTINY-Breast01] Interventricular Delay of Lumax HF-T for Heart Failure Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia Longitudinal Surveillance Registry (LSR) of ACUITY Spiral Evaluation of Handheld Colonoscopy Force Monitor by Expert Endoscopists in the Performance of Colonoscopy Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy Treatment Resistance Following Anti-cancer Therapies XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer Pivotal Study of eCoin for OAB With UUI Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
is research site of	wds:Q63578653-E42BF8A4-E182-45F5-A0E4-D2894B804653 wds:Q65315954-7A194EAB-2059-4065-9F08-B2621033BF50 wds:Q66067401-C17235CA-D295-4E2B-935F-2D6CFAF67D8F wds:Q100788540-25F32F23-AFAC-442D-AF1A-889699006EAC wds:Q61969570-24B75A80-CB37-48C1-8709-623EC128DC06 wds:Q64042956-E9F6A918-6BFB-49B4-9DF3-300557904188 wds:Q64722169-00886D05-045A-4909-97BE-CE728CD2D686 wds:Q66343464-B31E186A-09A2-4BA8-9CC3-0F9ECFBF8B9B wds:Q63576224-DC48A765-FF78-474A-9377-4B50F8A14AF6 wds:Q64644766-822442F4-DADB-49B7-8F42-E8813E8C806F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software